CMC Biologics

About:

CMC Biologics A/S provides biopharmaceutical contract manufacturing services. It offers microbial fermentation and mammalian cell culture

Website: http://www.cmcbio.com

Top Investors: Monitor Clipper Funds, Innoven Partners, European Equity Partners

Description:

CMC Biologics A/S provides biopharmaceutical contract manufacturing services. It offers microbial fermentation and mammalian cell culture based cGMP manufacturing services, such as process development and scale-up of protein processes; and production of biopharmaceuticals for pre-clinical, clinical trials, and market supply. The company also provides consultancy in facility design, quality, and regulatory issues; technology evaluation; and analytical development and quality control services. CMC Biologics A/S was formerly known as CMC Biopharmaceuticals A/S. The company was incorporated in 2001 and is headquartered in Copenhagen, Denmark with additional offices in the United States and the United Kingdom.